Tigecycline-Induced Acute Pancreatitis with Electrocardiogram Changes in Renal Insufficiency Elderly

Hong Chin Wee1,2, Ru Shing Ng1,2, Loke Meng Ong1,3

  • 1Clinical Research Centre, Hospital Pulau Pinang, Georgetown, Malaysia; Ministry of Health, Putrajaya, Malaysia.

Abstract

Insights

Tigecycline, a broad-spectrum antibiotic, can cause acute pancreatitis, a serious complication. Elderly patients with multiple health issues are particularly at risk for this adverse drug reaction.

Area of Science:

  • Pharmacology
  • Internal Medicine
  • Gastroenterology

Background:

  • Rising antimicrobial resistance necessitates broad-spectrum antibiotics like tigecycline.
  • Tigecycline is used for complex skin, intra-abdominal infections, and pneumonia.
  • Tigecycline use is associated with serious complications, including acute pancreatitis.

Purpose of the Study:

  • To report a case of acute pancreatitis induced by tigecycline.
  • To highlight the risks of tigecycline in elderly patients with comorbidities.

Main Methods:

  • A case study of a 78-year-old male patient with type 2 diabetes, renal insufficiency, and cardiovascular disease.
  • Diagnosis of acute pancreatitis confirmed via Magnetic Resonance Imaging (MRI).

Main Results:

  • The patient developed acute pancreatitis six days after starting tigecycline.
  • Discontinuation of tigecycline and supportive care led to recovery from pancreatitis.
  • The patient's underlying cardiac condition ultimately led to his death.

Conclusions:

  • Tigecycline can induce acute pancreatitis, especially in elderly patients with multiple comorbidities.
  • Risk factors for adverse drug reactions must be recognized for effective patient management.
  • Diagnostic imaging choices (e.g., MRI vs. CT) require tailoring to patient's renal status.

Related Concept Videos

Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
93
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
515
Acute Pancreatitis I: Introduction01:27

Acute Pancreatitis I: Introduction

Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
334
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
11.1K
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
62
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.2K